United States (US) Continuous Subcutaneous Insulin Infusion Market (2025-2031) | Value, Share, Analysis, Outlook, Competitive Landscape, Segmentation, Companies, Growth, Forecast, Size & Revenue, Industry, Trends

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Continuous Subcutaneous Insulin Infusion Market - Industry Life Cycle

3.4 United States (US) Continuous Subcutaneous Insulin Infusion Market - Porter's Five Forces

3.5 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.6 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume Share, By End Use, 2021 & 2031F

3.7 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume Share, By Patient Type, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of diabetes in the United States

4.2.2 Growing awareness about the benefits of continuous subcutaneous insulin infusion therapy

4.2.3 Technological advancements in insulin pump devices

4.2.4 Favorable reimbursement policies for diabetes management

4.2.5 Preference for non-invasive insulin delivery methods

4.3 Market Restraints

4.3.1 High cost associated with continuous subcutaneous insulin infusion therapy

4.3.2 Limited accessibility to advanced insulin pump technologies in certain regions

4.3.3 Concerns regarding the accuracy and reliability of insulin pump devices

4.3.4 Regulatory challenges and stringent approval processes for new devices

4.3.5 Competition from alternative diabetes management solutions

6.1 United States (US) Continuous Subcutaneous Insulin Infusion Market, By Product Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Product Type, 2021- 2031F

6.1.3 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Tethered, 2021- 2031F

6.1.4 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Patch, 2021- 2031F

6.2 United States (US) Continuous Subcutaneous Insulin Infusion Market, By End Use

6.2.1 Overview and Analysis

6.2.2 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Hospitals, 2021- 2031F

6.2.3 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Homecare, 2021- 2031F

6.2.4 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Laboratories, 2021- 2031F

6.3 United States (US) Continuous Subcutaneous Insulin Infusion Market, By Patient Type

6.3.1 Overview and Analysis

6.3.2 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Type 1 diabetes, 2021- 2031F

6.3.3 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Type 2 diabetes, 2021- 2031F

7.1 United States (US) Continuous Subcutaneous Insulin Infusion Market Export to Major Countries

7.2 United States (US) Continuous Subcutaneous Insulin Infusion Market Imports from Major Countries

8.1 Patient adherence rate to continuous subcutaneous insulin infusion therapy

8.2 Rate of adoption of insulin pump therapy among diabetes patients

8.3 Average time taken for insulin pump manufacturers to bring new products to market

8.4 Number of clinical trials and studies supporting the efficacy of continuous subcutaneous insulin infusion therapy

8.5 Percentage of healthcare providers recommending insulin pump therapy to their patients

9.1 United States (US) Continuous Subcutaneous Insulin Infusion Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.2 United States (US) Continuous Subcutaneous Insulin Infusion Market Opportunity Assessment, By End Use, 2021 & 2031F

9.3 United States (US) Continuous Subcutaneous Insulin Infusion Market Opportunity Assessment, By Patient Type, 2021 & 2031F

10.1 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenue Share, By Companies, 2024

10.2 United States (US) Continuous Subcutaneous Insulin Infusion Market Competitive Benchmarking, By Operating and Technical Parameters